Cargando…

Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia

Dysregulation of the dopamine system is central to many models of the pathophysiology of psychosis in schizophrenia. However, emerging evidence suggests that this dysregulation is driven by the disruption of upstream circuits that provide afferent control of midbrain dopamine neurons. Furthermore, s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sonnenschein, Susan F., Gomes, Felipe V., Grace, Anthony A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350524/ https://www.ncbi.nlm.nih.gov/pubmed/32719622 http://dx.doi.org/10.3389/fpsyt.2020.00613

Ejemplares similares

Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain
por: Purves-Tyson, T D, et al.
Publicado: (2017)

The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability
por: Gomes, Felipe V., et al.
Publicado: (2019)

Evidence for Schizophrenia-Specific Pathophysiology of Nicotine Dependence
por: Ward, Heather Burrell, et al.
Publicado: (2022)

Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia
por: Purves-Tyson, Tertia D., et al.
Publicado: (2021)

Magnetic resonance imaging of the dopamine system in schizophrenia – A scoping review
por: Schulz, Julia, et al.
Publicado: (2022)

Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention
por: Gomes, Felipe V., et al.
Publicado: (2021)

Neuroimaging as a Window Into the Pathophysiological Mechanisms of Schizophrenia
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2021)

Dopamine System Dysregulation in Major Depressive Disorders
por: Belujon, Pauline, et al.
Publicado: (2017)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders
por: Murray, Alex J., et al.
Publicado: (2021)

Dysregulated noradrenergic response is associated with symptom severity in individuals with schizophrenia
por: Pelegrino, Ana, et al.
Publicado: (2023)

Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?
por: Du, Xin, et al.
Publicado: (2015)

S37. STATE-DEPENDENT EFFECTS OF D2 PARTIAL AGONIST ARIPIPRAZOLE ON DOPAMINE NEURON ACTIVITY IN THE MAM NEURODEVELOPMENTAL MODEL OF SCHIZOPHRENIA
por: Sonnenschein, Susan, et al.
Publicado: (2018)

Use of prepubertal environment enrichment to prevent dopamine dysregulation in a neurodevelopmental rat model of schizophrenia risk
por: Zhu, Xiyu, et al.
Publicado: (2022)

Dopamine Pathology in Schizophrenia: Analysis of Total and Phosphorylated Tyrosine Hydroxylase in the Substantia Nigra
por: Perez-Costas, Emma, et al.
Publicado: (2012)

Schizophrenia and Hereditary Polyneuropathy: PMP22 Deletion as a Common Pathophysiological Link?
por: Endres, Dominique, et al.
Publicado: (2019)

Unraveling the pathophysiology of schizophrenia: insights from structural magnetic resonance imaging studies
por: Adamu, Mohammed Jajere, et al.
Publicado: (2023)

Transient Dysregulation of Dopamine Signaling in a Developing Drosophila Arousal Circuit Permanently Impairs Behavioral Responsiveness in Adults
por: Ferguson, Lachlan, et al.
Publicado: (2017)

Reinforcement Learning and Dopamine in Schizophrenia: Dimensions of Symptoms or Specific Features of a Disease Group?
por: Deserno, Lorenz, et al.
Publicado: (2013)

Reliability in the Identification of Midbrain Dopamine Neurons
por: Margolis, Elyssa B., et al.
Publicado: (2010)

Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
por: de Bartolomeis, Andrea, et al.
Publicado: (2020)

The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
por: Brisch, Ralf, et al.
Publicado: (2014)

Are CB2 Receptors a New Target for Schizophrenia Treatment?
por: Cortez, Isadora L., et al.
Publicado: (2020)

Chronic Ketamine Administration Modulates Midbrain Dopamine System in Mice
por: Tan, Sijie, et al.
Publicado: (2012)

Corrigendum: The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
por: Brisch, Ralf, et al.
Publicado: (2014)

Purity and Enrichment of Laser-Microdissected Midbrain Dopamine Neurons
por: Brown, Amanda L., et al.
Publicado: (2013)

Anatomical Templates of the Midbrain Ventral Tegmental Area and Substantia Nigra for Asian Populations
por: Nakamura, Yuko, et al.
Publicado: (2018)

The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review
por: Maletic, Vladimir, et al.
Publicado: (2017)

Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1–aging and epigenomics
por: Reece, Albert Stuart, et al.
Publicado: (2023)

Synchronicity: The Role of Midbrain Dopamine in Whole-Brain Coordination
por: Beeler, Jeff A., et al.
Publicado: (2019)

Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2—Metabolome, immunome, synaptome
por: Reece, Albert Stuart, et al.
Publicado: (2023)

No Influence of Dopamine System Gene Variations on Acute Effects of MDMA
por: Vizeli, Patrick, et al.
Publicado: (2019)

Midbrain dopamine neurons arbiter OCD-like behavior
por: Xue, Jinwen, et al.
Publicado: (2022)

Expression of Dopamine D(1−4) and Serotonin 5-HT(1A-3A) Receptors in Blood Mononuclear Cells in Schizophrenia
por: Wysokiński, Adam, et al.
Publicado: (2021)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Batinic, Borjanka, et al.
Publicado: (2021)

CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson’s disease
por: Pakarinen, Emmi, et al.
Publicado: (2023)

Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders
por: Burns, Jamie A., et al.
Publicado: (2019)

Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease
por: Chen, Allen PF, et al.
Publicado: (2021)

Subcellular and regional localization of mRNA translation in midbrain dopamine neurons
por: Hobson, Benjamin D., et al.
Publicado: (2022)

Mobilization of endocannabinoids by midbrain dopamine neurons is required for the encoding of reward prediction
por: Luján, Miguel Á., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s93v5g2r88v7vlc7jhh7b1u2q7